XOMA is a leading biopharmaceutical company in the field of therapeutic antibody discovery and development. We have a royalty interest in one approved therapeutic antibody, RAPTIVAŽ (efalizumab),... www.xoma.com/View full profile
TL Biopharmaceuticals Ltd. ("XTL") is engaged in the acquisition, development and commercialization of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine,... www.xtlbio.comView full profile
Xtrana's mission is to simplify the analysis of DNA/RNA, so that nucleic acid based detection systems can be utilized not only in traditional laboratory settings, but also in point-of-care, point-of... www.xtrana.com/View full profile